PTU - Polskie Towarzystwo Urologiczne
list of articles:

Meteses as the symptom of the testicle carcinoma
Article published in Urologia Polska 1993/46/4.

authors

Jerzy Świerż, Bronisław Stawarz, Andrzej Gomuła
Z Kliniki Urologii Centralnego Szpitala Klinicznego WAM
Kierownik Kliniki: Prof. dr hab. med. B. Stawarz

summary

Retrospective analysis of 87 patients with carcinoma of the testicle was conducted. We
found that in 13% of patients first symptoms came from metastatic foci in abdominal lymph
nodes and pulmonary metastases and were seemingly disconnected with carcionoma of the
testicle. In 75% of patients the primary lesion was symptomless, detectable by ultrasonography
examination. Neoplasm biochemie markers concentration increased with the neoplasm clinical
progression degree. It is emphasised that in young males the oceurance of sound health
non-typical abdominal pains, cough, dyspnoea or haenoptysis among other symptoms could
suggest possibility of malignant carcinoma of the testicle

references

  1. I. Adamkiewicz K.: Złośliwe nowotwory jądra i ich leczenie. Urol. Pol., 1987, 40, 1. —
  2. 2.Bali D., Barrett A., Peckham M.: The management of metastatic semionoma testis. Cancer, 1982, 50, 2289. —
  3. 3. Clamon G., Henry K., Loening S.:Symptoms in patiens with germ cell neoplasms. Urologe, 1990, 36, 465. —
  4. 4. Collins P., Pugh R.: Classification and freąuency of testicular tumors. Br J. Urol., 1974, 36, 1. —
  5. 5. Fossa S., Borge L., Aass M.\\\\ The treatment of advanced metastatic seminoma. J. Clin. Oncol., 1987, 5, 1071. —
  6. 6. Hesketh P., Krane R.: Prognostic assessement in nonseminomatous testicular cancer. J. Urol., 1990, 144, 1. —
  7. 7. Jensen O., EsteveJ., Renard H.: Cancer in the Europen Community and its member states. Eur. J. Cancer., 1990, 11/12, 1167. —
  8. 8. Klepp O., Olsson A., Henrikson H.: Prognostic factors in nonseminomatous germ cell tumors of the testis. J. Clin. Onkol., 1990, 8, 509. —
  9. 9. Mackey E., Selers A.: A statistical review of malignant testicular tumors based on the expirience of the Ontario Cancer Foundation Clinics. Can. Med. Assoc. J., 1966, 94, 889. —
  10. 10. Madej G.: Skojarzone chemiczne i chirurgiczne, radykalne leczenie chorych na nienasieniaki. Nowotwory, 1984, 4, 306.
  11. II.Mann K.: Tumor markers in testicular carcinoma. Urologe, 1990, 36, 465. —
  12. 12. Mostofi F.: Histopatological typing of testis tumors. International histopatological elassyfication of tumors, WHO, Geneva, 1977. —
  13. 13. Patton J., Sietzman D., Zone R.: Diagnosis and treatment of testicular tumors. Am. J. Surg., 1970, 99, 525. —
  14. 14. Prise P., Hogan S., Horowich A.: The growth rate of metastatic nonseminomatous germ cell testicular tumours. Eur. J. Cancer, 1990, 26, 450.
  15. 15. Robson C, Bruce A., Charbonneau P.\\\\ Testicular tumors. J. Urol., 1965, 94, 440. —
  16. 16. Toner G., Geller N., Ten C:Serum tumor marker halflife during chemotherapy allows early predietion of complete response and survival in nonseminomatous germ cell tumors. Cancer Res., 1990, 50, 5904. —
  17. 17. Yehinsky T., Jaschke W., Vermund H.\\\\ Testicular tumors. An analysis of 112 consecutive cases Am. J. Roentgen., 1965, 95, 494. —
  18. 18. Zatoński W.: Nowotwory złośliwe w Polsce w 1989 roku. Biuletyn Instytutu Onkologii, 1992, 31.

correspondence

dr. med. Jerzy Swierż,
Klinika Urologii Centralnego Szpitala Klinicznego WAM.
00-909 Warszawa, ul. Szaserów 128,